There is an incredible need for interdisciplinary relationships to ensure the best of patient care for NAFLD and NASH. This is an excellent presentation by Dr. Mark Swain, Hepatologist.
Post American Association for the Study of Liver Diseases (AASLD) #tlm22 NAFLD and NASH highlights chat with Dr. Mark Swain, Hepatologist.
Non-invasive tests: Upsides and downsides - "...an area of significant ongoing effort and energy". Fib-4/Agile 3+/Agile 4
Socio-economic drivers of NASH: "Mediterranean diets are expensive." "It can be very hard if people don't have the financial means to be able to afford this diet".
Here's a quick post-AASLD, #tlm22 update from Dr. Giada Sebastiani sharing her top NAFLD and NASH take ways from the 2022 American Association for the Study of Liver Diseases (AASLD) conference.
"Lifestyle modification is still a cornerstone for the treatment of NAFLD and NASH". Giada refers to 3 studies.
Non-invasive tests: Fib-4 subtleties of use with referrals to studies. "Sequential algorithms of tests..is the way to go."
Very interesting data presented on therapeutics: "The future is bright".
A Year in Review - NASH 2021 - Post AASLD with Dr. Mark Swain, Michael Betel, Dr. Giada Sebastiani, Dr. Alnoor Ramji and Dr. Keyur Patel.